EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Diagnosis and Management of Attention-Deficit/Hyperactivity Disorder: A Practitioner’s Perspective

Mansour M Alotaibi iD, Naif Z Alrashdi iD, Sultan A Alanazi iD, Marzouq K Almutairi iD, Bakriah Y Alzubaidi, Maraheb M Alkhalidi iD, Deemah Alateeq iD, Mohammed M Alqahtani

Journal of Clinical Medicine · 22.04.2025 · 14 (9) · 2874

DOI: 10.3390/jcm14092874 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 22.04.2025. Verfasst von Mansour M Alotaibi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rehabilitation, Faculty of Applied Medical Sciences, Northern Border University, Arar 73213, Saudi Arabia. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: King Salman Center for Disability Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objective: Attention-deficit/hyperactivity disorder (ADHD) is a common neurodevelopmental disorder in Saudi Arabia, yet challenges remain in diagnosis and treatment accessibility. This study examined healthcare practitioners’ clinical approaches to ADHD diagnosis and management in Saudi Arabia and identified gaps in practice.

Methods

This cross-sectional study included healthcare practitioners working in various healthcare settings across Saudi Arabia. The sample included psychiatrists, pediatricians, psychologists, and other relevant specialists. Clinical practices regarding ADHD diagnosis, the use of ADHD screening tools, adherence to the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) criteria, treatment strategies, medication prescription protocols, and reported challenges were investigated.

Results

A total of 43 licensed healthcare practitioners with a minimum of 2 years of clinical experience managing ADHD participated. Among participants, 81.4% were psychiatrists, and 53.5% managed ADHD cases in children/adolescents exclusively. Approximately 86.0% of the sample used screening tools, with the Vanderbilt Assessment Scale being the most used (67.6%). However, only 55.8% addressed all 18 DSM-5 ADHD symptoms during the evaluation. Combined pharmacological and non-pharmacological treatment approaches (74.4%) were preferred. Interestingly, only 7.0% prescribed amphetamine-based stimulants due to the lack of clear guidelines. Key barriers included a lack of early screening programs (65.1%), limited ADHD medication option availability (51.2%), and extended referral waiting lists (44.2%).

Conclusions

Significant variability in ADHD diagnosis and treatment practices was evident among healthcare providers in Saudi Arabia. Specifically, a large proportion of healthcare providers do not fully comply with the standard DSM-5 diagnosis criteria. Major barriers to ADHD diagnosis and treatment in Saudi Arabia include extended referral waiting lists, limited availability of psychostimulant medications, and standardized clinical guidelines. A national ADHD protocol must be advocated, and access to diverse treatment options should be improved.

Schlagwörter

Stichwörter der Autor:innen

ADHDassessmentbarriersstimulants

Autor:innen und Institutionen

  • Department of Rehabilitation, Faculty of Applied Medical Sciences, Northern Border University, Arar 73213, Saudi Arabia.
  • King Salman Center for Disability Research, Riyadh 11614, Saudi Arabia.
  • Department of Physical Therapy and Health Rehabilitation, College of Applied Medical Sciences, Majmaah University, Al-Majmaah 11952, Saudi Arabia.
  • Health and Basic Sciences Research Center, Majmaah University, Al Majma'ah 11952, Saudi Arabia.
  • Department of Physical Therapy, College of Applied Medical Sciences, Qassim University, Buraydah 51452, Saudi Arabia.
  • Department of Rehabilitation Medicine, King Salman Specialist Hospital, Ministry of National Guard Health Affairs, Taif 11426, Saudi Arabia.

ORCID-Profile: Mansour M Alotaibi, Naif Z Alrashdi, Sultan A Alanazi, Marzouq K Almutairi, Maraheb M Alkhalidi, Deemah Alateeq

Förderung

  • King Salman Center for Disability Research

Zitieren

APA

Alotaibi, M. M., Alrashdi, N. Z., Alanazi, S. A., Almutairi, M. K., Alzubaidi, B. Y., Alkhalidi, M. M., Alateeq, D., & Alqahtani, M. M. (2025). Diagnosis and Management of Attention-Deficit/Hyperactivity Disorder: A Practitioner’s Perspective. Journal of Clinical Medicine, 14(9), 2874. https://doi.org/10.3390/jcm14092874

Vancouver

Alotaibi MM, Alrashdi NZ, Alanazi SA, Almutairi MK, Alzubaidi BY, Alkhalidi MM, et al. Diagnosis and Management of Attention-Deficit/Hyperactivity Disorder: A Practitioner’s Perspective. Journal of Clinical Medicine. 2025;14(9):2874. doi:10.3390/jcm14092874

BibTeX
@article{Alotaibi2025,
  author = {Alotaibi, Mansour M and Alrashdi, Naif Z and Alanazi, Sultan A and Almutairi, Marzouq K and Alzubaidi, Bakriah Y and Alkhalidi, Maraheb M and Alateeq, Deemah and Alqahtani, Mohammed M},
  title = {Diagnosis and Management of Attention-Deficit/Hyperactivity Disorder: A Practitioner’s Perspective},
  journal = {Journal of Clinical Medicine},
  year = {2025},
  volume = {14},
  number = {9},
  pages = {2874},
  doi = {10.3390/jcm14092874}
}
Kostenlos starten →